FDA Recommends Removing Suicide Warnings from Specific Weight-Loss Medications

The U.S. Food and Drug Administration (FDA) has requested the removal of suicide warnings from the labels of some weight-loss drugs. This decision is based on evolving evidence regarding the safety profiles of these medications. Patients using these drugs should continue to monitor for side effects and consult healthcare professionals with any concerns, as the removal does not negate all potential psychiatric effects.